Health knowledge made personal
Join this community!
› Share page:
Search posts:

Breast Cancer Breakthrough

Posted Oct 01 2008 10:28pm 1 Comment
Good news for women: A large government sponsored study of nearly 20,000 postmenopausal women found that raloxifene (marketed under the name of Evista) reduces their chance of developing breast cancer as effectively as tamoxifen, the only drug previously shown to reduce the risk, but is less likely to cause serious side effects such as uterine cancer and blood clots.

Because an estimated 500,000 women use raloxifene to reduce the risk of osteoporosis, many will be more comfortable using it for breast cancer protection, several experts predicted.

"It's terrific," said Susan Love, a breast cancer expert at the University of California at Los Angeles. "This gives us another drug that we can use to prevent breast cancer that is less risky than the only other drug we had."

Several experts, however, urged caution, saying that the advantage of raloxifene remains unclear and that more research is needed to prove the drug reduced the overall risk over longer periods.

Comments (1)
Sort by: Newest first | Oldest first
This is a good thing for all the women out there! For those that have lives and don't care about the latest cell phones (those silly people that have things to do and girlfriends and such) the Samsung Moment is a new smart phone, based on the Android operating system.  It will be carried exclusively by Sprint, although it isn't the only smart phone that Sprint offers with Android capabilities.  It features a touch screen, and a full QWERTY keyboard, 3G and all the digital bells and whistles you can shake a stick at.  One would imagine that with the release of the Samsung Moment a veritable bevy of people whose Blackberry just isn't new enough will be getting unsecured personal loans to get one.
Post a comment
Write a comment:

Related Searches